Mat Todd

See the following -

Africa: Potential New Class Of Antimalarials Now Open Source

Staff Writer | allAfrica | September 10, 2013

This week, MMV hands the triazolopyrazines and their key data over to Dr Mat Todd at the University of Sydney, where research on these potential antimalarials will continue for all the world to see as part of the Open Source Malaria project. Read More »

Can A Mobile App Boost The Signal About Rare And Neglected Diseases?

Alex Clark | Pistoia Alliance | September 12, 2012

One of the great things about mobile apps is that they are low-profile, easy-to-adopt tools that theoretically could remove traditional barriers between information sources...Nowhere is this more evident, or more important, than in the area of rare and neglected disease research, where disparate (and often desperate) information seekers need better ways to access and share information. Read More »

New Open Source Drug Discovery Project Aims to Develop Mycetoma Treatment

Press Release | ErasmusMC , University of Sydney , DNDi | February 6, 2018

The MycetOS (Mycetoma Open Source) project was launched today by the University of Sydney, Erasmus MC, and the Drugs for Neglected Diseases initiative (DNDi) to use an Open Pharma approach to discover compounds that could lead to new treatments for patients suffering from fungal mycetoma (eumycetoma), a devastating disease for which current treatments are ineffective, expensive, and toxic.